A brief review on colon-specific drug delivery system for targeting to colonic region
DOI:
https://doi.org/10.18231/j.joapr.2021.9.15Keywords:
Nanoparticles, Amoebiasis, Inflammatory bowel disease, Colorectal cancer, colonic dysmotility, chronic diarrheaAbstract
Drug delivery to the colonic region refers to the drug that should have to released in the colonic environment instead of released in the upper gastrointestinal tract. To reach the site-specificity of the local treatment of the colon such as amoebiasis, colorectal cancer, and inflammatory bowel disease the target-specific drug delivery played an important role. To the establishment of the target-specific drug delivery to the colon, the various approach that has been explored include pH-dependent polymer, time-dependent, and bacteria-dependent drug delivery approach. Nanotechnology has been gaining much more interest due to target specificity and enhancement of bioavailability and high loading capacity. In this review, oral nanoparticle formulation for colon targeting specifically inflammatory bowel disease and suitable drugs for useful treatment and future aspects of nanoparticle formulation with particular approaches to enhancement of drug stability in the gastric environment have been covered.
Downloads
References
Lu L, Chen G, Qiu Y, Li M, Liu D, Hu D, Gu X, Xiao Z. Nanoparticle-based oral delivery systems for colon targeting: principles and design strategies. Science Bulletin, 61(9), 670-681(2016)
Saha RN, Vasanthakumar S, Bende G, Snehalatha M. Nanoparticulate drug delivery systems for cancer chemotherapy. Molecular membrane biology, 27(7), 215-231(2010)
Hua S, Marks E, Schneider JJ, Keely S. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomedicine: nanotechnology, biology and medicine, 11(5), 1117-1132(2015)
Guo Y, Zong S, Pu Y, Xu B, Zhang T, Wang B. Advances in pharmaceutical strategies enhancing the efficiencies of oral colon-targeted delivery systems in inflammatory bowel disease. Molecules, 23(7), 1622-1625(2018)
Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Advanced drug delivery reviews, 64, 24-36(2012)
Nimmons D, Limdi JK. Elderly patients and inflammatory bowel disease. World journal of gastrointestinal pharmacology and therapeutics,7(1), 51-53(2016)
Abhishek SB, Parthiban S, Kumar GS, Mani TT. Microparticle as Suitable Drug Carriers for Colon Targeting-A Recent Review. American Journal of PharmTech Research, 8(1), 46-50(2018)
Singh CK, Saxena S, Yadav M, Samson AL. A review on novel approaches for colon-targeted drug delivery systems. PharmaTutor, 6(7), 11-22 (2018)
Philip AK, Philip B. Colon targeted drug delivery systems: a review on primary and novel approaches. Oman medical journal, 25(2), 79-81 (2010)
Singh A, Sharma A, Kaur S. Micro carrier as colon drug delivery system: a review. International Journal of Research and Development in Pharmacy & Life Sciences, 3(6), 1211-1216 (2014)
Pinto JF. Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon. International journal of pharmaceutics, 395(1-2), 44-52 (2010)
Dressman JB, Berardi RR, Dermentzoglou LC, Russell TL, Schmaltz SP, Barnett JL, Jarvenpaa KM. Upper gastrointestinal (GI) pH in young, healthy men and women. Pharmaceutical Research, 7(7), 756-61 (1990)
Abhishek SB, Parthiban S, Kumar GS, Mani TT. Microparticle as Suitable Drug Carriers for Colon Targeting–A Recent Review. American Journal of PharmTech Research, 8(1), 45-46 (2018)
Van den Mooter G, Samyn C, Kinget R. Azo polymers for colon-specific drug delivery. International journal of pharmaceutics, 87(1-3), 37-46 (1992)
Qureshi AM, Momin M, Rathod S, Dev A, Kute C. Colon targeted drug delivery system: A review on current approaches. Indian Journal of Pharmaceutical and Biological Research, 1(04), 130-47 (2013)
Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. New England Journal of Medicine, 317(26), 1625-1629 (1987)
Ashford M, Fell J, Attwood D, Sharma H, Woodhead P. An evaluation of pectin as a carrier for drug targeting to the colon. Journal of Controlled Release, 26(3), 213-220 (1993)
Mehta TJ, Patel AD, Patel MR, Patel NM. Need of colon-specific drug delivery system: review on primary and novel approaches. IJPRD, 3(1), 134-153 (2011)
Verma S, Kumar V, Mishra DN, Singh SK. Colon targeted drug delivery: current and novel perspectives. International Journal of Pharmaceutical Sciences and Research, 3(5), 1274-1278 (2012)
Metwally AA, Hathout RM. Computer-assisted drug formulation design: a novel approach in drug delivery. Molecular Pharmaceutics, 12(8), 2800-2810 (2015)
Singh A, Malviya R, K Sharma P. Pulmonary drug delivery system: a novel approach for drug delivery. Current Drug Therapy, 6(2), 137-51 (2011)
Patel M, Shah A, Patel NM, Patel MR, Patel KR. Nanosuspension: A novel approach for drug delivery system. Jpsbr, 1(1), 1-10 (2011)
Abhishek SB, Parthiban S, Kumar GS, Mani TT. Microparticle as Suitable Drug Carriers for Colon Targeting–A Recent Review. American Journal of PharmTech Research, 8(1), 53-57 (2018)
Xiao B, Merlin D. Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease. Expert opinion on drug delivery, 9(11), 1393-407 (2012)
Gamucci O, Bertero A, Gagliardi M, Bardi G. Biomedical nanoparticles: an overview of their surface immune-compatibility. Coatings, 4(1), 139-59 (2014)
Ju-Nam Y, Lead JR. Manufactured nanoparticles: an overview of their chemistry, interactions, and potential environmental implications. Science of the total environment, 400(1-3), 396-414 (2008)
Bahadar H, Maqbool F, Niaz K, Abdollahi M. Toxicity of nanoparticles and an overview of current experimental models. Iranian biomedical journal, 20(1), 1-5 (2016)
Dhand C, Dwivedi N, Loh XJ, Ying AN, Verma NK, Beuerman RW, Lakshminarayanan R, Ramakrishna S. Methods and strategies for the synthesis of diverse nanoparticles and their applications: a comprehensive overview. Rsc Advances, 5(127), 105003-105037(2015)
Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA-based nanoparticles: an overview of biomedical applications. Journal of controlled release, 161(2), 505-22 (2012)
Sánchez-López E, Gomes D, Esteruelas G, Bonilla L, Lopez-Machado AL, Galindo R, Cano A, Espina M, Ettcheto M, Camins A, Silva AM. Metal-based nanoparticles as antimicrobial agents: an overview. Nanomaterials, 10(2), 292 (2020)
You X, Kang Y, Hollett G, Chen X, Zhao W, Gu Z, Wu J. Polymeric nanoparticles for colon cancer therapy: overview and perspectives. Journal of Materials Chemistry B, 4(48), 7779-7792 (2016)
Ajitkumar BN, Kumar L. Treating colon cancers with a non-conventional yet strategic approach: An overview of various nanoparticulate systems. Journal of Controlled Release, 336, 16-39 (2021)
Mohammed MA, Syeda J, Wasan KM, Wasan EK. An overview of chitosan nanoparticles and their application in non-parenteral drug delivery. Pharmaceutics, 9(4), 53-57 (2017)
Kumari B, Upadhyay PK, Kumar M, Narwal S, Pandurangan A, Malik A. An updated overview of recent advances on formulation development for colon targeting. IJPSR, 11(4), 1571-1580 (2020)
Pelka J, Gehrke H, Esselen M, Türk M, Crone M, Bräse S, Muller T, Blank H, Send W, Zibat V, Brenner P. Cellular uptake of platinum nanoparticles in human colon carcinoma cells and their impact on cellular redox systems and DNA integrity. Chemical research in toxicology, 22(4), 649-659 (2009)
Bahadar H, Maqbool F, Niaz K, Abdollahi M. Toxicity of nanoparticles and an overview of current experimental models. Iranian biomedical journal, 20(1), 1-11 (2016)
Kumar P, Mishra B. Colon targeted drug delivery systems-an an overview. Current drug delivery, 5(3), 186-198 (2008)
Naeem M, Awan UA, Subhan F, Cao J, Hlaing SP, Lee J, Im E, Jung Y, Yoo JW. Advances in colon-targeted nano-drug delivery systems: challenges and solutions. Archives of pharmacal research, 43(1), 153-169 (2020)
Al-Zharani M, Qurtam AA, Daoush WM, Eisa MH, Aljarba NH, Alkahtani S, Nasr FA. Antitumor effect of copper nanoparticles on human breast and colon malignancies. Environmental Science and Pollution Research, 28(2), 1587-1595 (2021)
Zhang AP, Sun YP. Photocatalytic killing effect of TiO2 nanoparticles on Ls-174-t human colon carcinoma cells. World Journal of Gastroenterology: World J Gastroenterol, 10(21), 3191-3193 (2004)
Desai KG. Chitosan nanoparticles prepared by ionotropic gelation: An overview of recent advances. Critical Reviews™ in Therapeutic Drug Carrier Systems, 33(2), 107-158 (2016)
Tortella GR, Rubilar O, Durán N, Diez MC, Martínez M, Parada J, Seabra AB. Silver nanoparticles: Toxicity in model organisms as an overview of its hazard for human health and the environment. Journal of hazardous materials, 390, 121974-121976 (2020)
Sunoqrot S, Abujamous L. pH-sensitive polymeric nanoparticles of quercetin as a potential colon cancer-targeted nanomedicine. Journal of Drug Delivery Science and Technology, 52, 670-676 (2019)
Pop OL, Vodnar DC, Diaconeasa Z, Istrati M, Bințințan A, Bințințan VV, Suharoschi R, Gabbianelli R. An Overview of Gut Microbiota and Colon Diseases with a Focus on Adenomatous Colon Polyps. International Journal of Molecular Sciences, 21(19), 7359-7365 (2020)
Barani M, Bilal M, Rahdar A, Arshad R, Kumar A, Hamishekar H, Kyzas GZ. Nanodiagnosis and nano treatment of colorectal cancer: An overview. Journal of Nanoparticle Research, 23(1), 1-25 (2021)
Naskar S, Sharma S, Kuotsu K. Chitosan-based nanoparticles: An overview of biomedical applications and its preparation. Journal of Drug Delivery Science and Technology, 49, 66-81(2019)
Published
How to Cite
Issue
Section
Copyright (c) 2021 Soumyadip Ghosh, Subhabrota Majumdar, Debgopal Ganguly
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
